Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Cervical Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07646301
What this trial is testing

Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmsLocally Advanced
Sun Yat-sen University 103
Large-scale testing (Phase 3)Active Not RecruitingNCT02466971
What this trial is testing

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Who this might be right for
Advanced Vaginal AdenocarcinomaAdvanced Vaginal Adenosquamous CarcinomaAdvanced Vaginal Squamous Cell Carcinoma+18 more
National Cancer Institute (NCI) 450
Not applicableStudy completedNCT00899821
What this trial is testing

Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07206563
What this trial is testing

Penfluridol for Relapsed/Refractory Small Cell Cancers

Who this might be right for
Small Cell CarcinomaSmall Cell Carcinoma of LungSmall Cell Lung Cancer ( SCLC )+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 33
Testing effectiveness (Phase 2)WithdrawnNCT05033132
What this trial is testing

A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Agenus Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06630611
What this trial is testing

Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Who this might be right for
MelanomaNon Small Cell Lung CancerCervical Cancer
Vall d'Hebron Institute of Oncology 40
Testing effectiveness (Phase 2)UnknownNCT01291095
What this trial is testing

Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma

Who this might be right for
HEAD AND NECK CANCER
All India Institute of Medical Sciences 80
Testing effectiveness (Phase 2)Ended earlyNCT00256295
What this trial is testing

Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Cancer of the Head and Neck
Sai-Hong Ignatius Ou 8
Testing effectiveness (Phase 2)Study completedNCT02979977
What this trial is testing

Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck

Who this might be right for
Squamous Cell Cancers of the Head and Neck
Yale University 50
Testing effectiveness (Phase 2)WithdrawnNCT01613677
What this trial is testing

Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer

Who this might be right for
Treatment for Metastatic or Locally Advanced Cervical Cancer
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT07381075
What this trial is testing

A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07824856
What this trial is testing

Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoplasm MetastasisLung Metastases+3 more
Sun Yat-sen University 138
Testing effectiveness (Phase 2)Looking for participantsNCT06056336
What this trial is testing

Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant ChemoimmunotherapyAdjuvant Therapy
Guo Xufeng 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT05340270
What this trial is testing

PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoadjuvant TherapyPD-1 Inhibitor
Guangxi Medical University 150
Testing effectiveness (Phase 2)Study completedNCT00343083
What this trial is testing

Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)

Who this might be right for
Cancer of Head and Neck
University of Maryland, Baltimore 43
Testing effectiveness (Phase 2)Looking for participantsNCT06675201
What this trial is testing

Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Neoantigen-loaded Dendritic Cell VaccineImmune Checkpoint Inhibitors (ICIs)
Sichuan University 165
Testing effectiveness (Phase 2)Study completedNCT03194373
What this trial is testing

Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Michigan Rogel Cancer Center 21
Testing effectiveness (Phase 2)Looking for participantsNCT07070466
What this trial is testing

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

Who this might be right for
Stomach Cancer Stage IVEsophagus CancerStomach Cancer
Massachusetts General Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT00006472
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer

Who this might be right for
Esophageal Cancer
Medstar Health Research Institute 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT05520619
What this trial is testing

Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)

Who this might be right for
Esophageal Squamous Cell CarcinomaLocally Advanced Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 114
Next Page